A business in context
ZTS research notebook
Read the disclosures. Follow the relationships. Keep the dates in view.
Filing timeline
Download filings CSVReported insider transactions
Download transactions CSVP · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift
| Transaction / filed | Reporting owner | Type | Security | Shares | Reported price |
|---|---|---|---|---|---|
| 2026-06-18 | Stetter Mark | A · Grant / award | Phantom Stock Unit | 317.62 | 78.71 |
| 2026-06-10 | MCCALLISTER MICHAEL B | G · Gift | Common Stock | 1209.0 | 0.0 |
| 2026-05-21 | Stetter Mark | M · Exercise / conversion | Common Stock | 1572.0 | — |
| 2026-05-21 | Stetter Mark | M · Exercise / conversion | Restricted Stock Unit | 1572.06 | — |
| 2026-05-20 | PARENT LOUISE M | M · Exercise / conversion | Common Stock | 10186.0 | — |
| 2026-05-20 | PARENT LOUISE M | M · Exercise / conversion | Common Stock | 1944.0 | — |
| 2026-05-20 | PARENT LOUISE M | M · Exercise / conversion | Deferred Stock Unit | 10186.67 | 0.0 |
| 2026-05-20 | PARENT LOUISE M | M · Exercise / conversion | Restricted Stock Unit | 1944.36 | 0.0 |
| 2026-05-13 | DAMELIO FRANK A | P · Purchase | Common Stock | 6650.0 | 75.39 |
| 2026-05-13 | Bisaro Paul | P · Purchase | Common Stock | 2000.0 | 75.88 |
| 2026-05-11 | MCCALLISTER MICHAEL B | P · Purchase | Common Stock | 3000.0 | 77.76 |
| 2026-04-30 | Esch Kevin | M · Exercise / conversion | Common Stock | 259.0 | — |
| 2026-04-30 | Esch Kevin | F · Tax / exercise payment | Common Stock | 75.0 | 114.97 |
| 2026-04-30 | Esch Kevin | M · Exercise / conversion | Restricted Stock Unit | 259.92 | — |
| 2026-04-10 | FULLER JULIE | A · Grant / award | Phantom Stock Unit | 550.64 | 39.64 |
| 2026-04-10 | Lagano Roxanne | A · Grant / award | Phantom Stock Unit | 550.64 | 39.64 |
| 2026-04-10 | Ferran Astorga Jeannette | A · Grant / award | Phantom Stock Unit | 5.0 | 39.64 |
| 2026-04-10 | Esch Kevin | A · Grant / award | Phantom Stock Unit | 1.39 | 39.64 |
| 2026-04-10 | PECK KRISTIN C | A · Grant / award | Phantom Stock Unit | 2776.77 | 39.64 |
| 2026-04-10 | Driscoll Rimma | A · Grant / award | Phantom Stock Unit | 26.2 | 39.64 |
| 2026-04-10 | Joseph Wetteny | A · Grant / award | Phantom Stock Unit | 873.95 | 39.64 |
| 2026-04-10 | Sarbaugh Keith | A · Grant / award | Phantom Stock Unit | 230.76 | 39.64 |
| 2026-03-31 | Sarbaugh Keith | M · Exercise / conversion | Common Stock | 1528.0 | — |
| 2026-03-31 | Sarbaugh Keith | F · Tax / exercise payment | Common Stock | 524.0 | 118.21 |
| 2026-03-31 | Sarbaugh Keith | M · Exercise / conversion | Restricted Stock Unit | 1528.02 | — |
Identity & relationships
wikidata · parent organizationPfizer
SEC issuer · 0001555280Zoetis Inc.
Zoetis (Canada)Zoetis India LtdZoetis (United Kingdom)
- Legal Entity Identifier
- 549300HD9Q1LOC9KLJ48
- GLEIF legal name
- ZOETIS INC.
- Entity / LEI registration status
- ACTIVE / ISSUED
- Reference data updated
- 2026-07-09T13:36:35Z
Search names and former names
View Wikidata identity and references ↗
- Zoetis · alias · wikidata
- Zoetis (Canada) · subsidiary · wikidata
- Zoetis India Ltd · subsidiary · wikidata
- Zoetis (United Kingdom) · subsidiary · wikidata
Revenue in constant purchasing power
| Year ended | Reported USD revenue | CPI-adjusted USD revenue |
|---|---|---|
| 2024-12-31 | $9.26B | $9.85B |
| 2023-12-31 | $8.54B | $9.36B |
| 2022-12-31 | $8.08B | $9.22B |
| 2021-12-31 | $7.78B | $9.58B |
| 2020-12-31 | $6.67B | $8.61B |
| 2019-12-31 | $6.26B | $8.18B |
| 2018-12-31 | $5.83B | $7.75B |
| 2017-12-31 | $5.31B | $7.23B |